Literature DB >> 8422626

Osteosarcoma. Low-grade intraosseous-type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma.

F Bertoni1, P Bacchini, N Fabbri, M Mercuri, P Picci, P Ruggieri, M Campanacci.   

Abstract

BACKGROUND: Low-grade intraosseous osteosarcoma is a rare variety of osteosarcoma and it is difficult to recognize.
METHODS: A series of 10 patients with low-grade intraosseous osteosarcoma is reported. These patients were identified from the Istituto Rizzoli files, which includes approximately 1000 cases of osteosarcoma. Clinical data and radiographic and histologic features were studied.
RESULTS: The radiographic appearance confirmed malignancy in five patients and suggested it in two. A benign lesion was diagnosed in three patients. Three lesions resembled parosteal osteosarcoma, two appeared similar to fibrous dysplasia, and two had features of desmoplastic fibroma. A mixed histologic pattern was found in three other tumors. Recurrence after intralesional excision in all patients indicated the aggressive nature of this lesion. The development of metastases in two patients and progression in the grade of malignancy in one of these highlighted the malignant nature of the tumor.
CONCLUSIONS: The correct diagnosis would permit adequate treatment with wide surgical margins.

Entities:  

Mesh:

Year:  1993        PMID: 8422626     DOI: 10.1002/1097-0142(19930115)71:2<338::aid-cncr2820710212>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Central low-grade osteosarcoma: a diagnostic challenge.

Authors:  S Fiona Bonar
Journal:  Skeletal Radiol       Date:  2012-02-07       Impact factor: 2.199

2.  Dedifferentiated high-grade osteosarcoma originating from low-grade central osteosarcoma of the fibula.

Authors:  Samuel Kenan; Daniel T Ginat; German C Steiner
Journal:  Skeletal Radiol       Date:  2006-07-01       Impact factor: 2.199

3.  Fibrous dysplasia: an unusual case of a very aggressive form with costo-vertebral joint destruction and invasion of the contralateral D7 vertebral body.

Authors:  Carmine Zoccali; Dario Attala; Barbara Rossi; Giovanni Zoccali; Virginia Ferraresi
Journal:  Skeletal Radiol       Date:  2018-05-23       Impact factor: 2.199

4.  The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.

Authors:  Abberly Lott Limbach; Mark W Lingen; James McElherne; Heather Mashek; Carrie Fitzpatrick; Elizabeth Hyjek; Reza Mostofi; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2020-02-05

5.  Multifocal low-grade central osteosarcoma: a rare case.

Authors:  Richard Boyle; Bruno Giuffre; S Fiona Bonar
Journal:  Skeletal Radiol       Date:  2016-04-05       Impact factor: 2.199

6.  A rare case of low-grade myofibroblastic sarcoma of the femur in a 38-year-old woman: a case report.

Authors:  Raman Arora; Ruchika Gupta; Alok Sharma; Amit K Dinda
Journal:  J Med Case Rep       Date:  2010-04-28

7.  Chromosome 12 long arm rearrangement covering MDM2 and RASAL1 is associated with aggressive craniofacial juvenile ossifying fibroma and extracranial psammomatoid fibro-osseous lesions.

Authors:  Flore Tabareau-Delalande; Christine Collin; Anne Gomez-Brouchet; Corinne Bouvier; Anne-Valérie Decouvelaere; Anne de Muret; Jean-Christophe Pagès; Gonzague de Pinieux
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

Review 8.  Premalignant conditions of bone.

Authors:  Andrew Horvai; K Krishnan Unni
Journal:  J Orthop Sci       Date:  2006-07       Impact factor: 1.601

9.  Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup.

Authors:  Jakob K Anninga; Piero Picci; Marta Fiocco; Herman M J A Kroon; Daniel Vanel; Marco Alberghini; Hans Gelderblom; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2012-12-05       Impact factor: 4.064

10.  Well-differentiated, low-grade osteosarcoma of the clivus.

Authors:  Y K Park; M H Yang; W S Choi; Y J Lim
Journal:  Skeletal Radiol       Date:  1995-07       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.